These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32158188)

  • 1. In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment.
    Dana H; Mahmoodi Chalbatani G; Gharagouzloo E; Miri SR; Memari F; Rasoolzadeh R; Zinatizadeh MR; Kheirandish Zarandi P; Marmari V
    Drug Des Devel Ther; 2020; 14():309-329. PubMed ID: 32158188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.
    Kalantari E; Taheri T; Fata S; Abolhasani M; Mehrazma M; Madjd Z; Asgari M
    World J Surg Oncol; 2022 Jan; 20(1):15. PubMed ID: 35016698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia.
    Walker BS; Zarour LR; Wieghard N; Gallagher AC; Swain JR; Weinmann S; Lanciault C; Billingsley K; Tsikitis VL; Wong MH
    World J Surg; 2020 Oct; 44(10):3501-3509. PubMed ID: 32647988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
    Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
    Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-informatics analysis and expression of a novel multi-domain antigen as a vaccine candidate against glioblastoma.
    Gharbavi M; Danafar H; Amani J; Sharafi A
    Int Immunopharmacol; 2021 Feb; 91():107265. PubMed ID: 33360829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Structural Prediction and Production of a Chimeric Recombinant Dickkopf-1 (DKK-1) Antigen.
    Malaei F; Rasaee MJ; Latifi AM; Rahbarizadeh F
    Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):269-280. PubMed ID: 31522434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional evaluation of recombinant histidine phosphokinase NisK and response regulator NisR: in silico and experimental approach.
    Heidari S; Hamedi J; Olad G; Amani J; Rastegar Shariat Panahi M; Najafi A
    World J Microbiol Biotechnol; 2019 Oct; 35(11):169. PubMed ID: 31654140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.
    Hansen AG; Freeman TJ; Arnold SA; Starchenko A; Jones-Paris CR; Gilger MA; Washington MK; Fan KH; Shyr Y; Beauchamp RD; Zijlstra A
    Cancer Res; 2013 May; 73(10):2955-64. PubMed ID: 23539446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioinformatics analysis and prokaryotic expression of
    Han X; Bi X; Zhao H; Shi Y; Wen Q; Lü J; Sun J; Fu X; Liu D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Jun; 35(3):244-250. PubMed ID: 37455094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An
    Fathi J; Nazarian S; Kordbacheh E; Hadi N
    Avicenna J Med Biotechnol; 2022; 14(3):247-258. PubMed ID: 36061128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico and experimental methods for designing a potent anticancer arazyme-herceptin fusion protein in HER2-positive breast cancer.
    Rahmani F; Imani Fooladi AA; Ajoudanifar H; Soleimani NA
    J Mol Model; 2023 Apr; 29(5):160. PubMed ID: 37103612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
    Solanki V; Tiwari M; Tiwari V
    Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of a vector encoding T-cell epitopes of Dermatophagoides pteronyssinus major allergen group 1 as a vaccine delivered by MHC class II pathway].
    Zhao B; Jiang Y; Diao J; Li N; Lu W; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):174-8. PubMed ID: 25736108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii.
    Dodangeh S; Fasihi-Ramandi M; Daryani A; Valadan R; Sarvi S
    Microb Pathog; 2019 Jul; 132():275-281. PubMed ID: 31078709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
    Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
    Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus.
    Hasan M; Azim KF; Begum A; Khan NA; Shammi TS; Imran AS; Chowdhury IM; Urme SRA
    Infect Genet Evol; 2019 Jun; 70():140-157. PubMed ID: 30849525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing of a chimeric protein contains StxB, intimin and EscC against toxicity and adherence of enterohemorrhagic Escherichia coli O157:H7 and evaluation of serum antibody titers against it.
    Sadri Najafabadi Z; Nazarian S; Kargar M; Kafilzadeh F
    Mol Immunol; 2021 Jun; 134():218-227. PubMed ID: 33823320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico study to unveil potential drugs and vaccine chimera for HBV capsid assembly protein: combined molecular docking and dynamics simulation approach.
    Ismail S; Waheed Y; Ahmad S; Ahsan O; Abbasi SW; Sadia K
    J Mol Model; 2022 Feb; 28(2):51. PubMed ID: 35112241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.